We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
101 hedge funds and large institutions have $330M invested in Kiniksa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
42% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 26
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
0.03% more ownership
Funds ownership: 89.28% → 89.31% (+0.03%)
1% less funds holding
Funds holding: 102 → 101 (-1)
11% less call options, than puts
Call options by funds: $3.15M | Put options by funds: $3.54M
18% less capital invested
Capital invested by funds: $402M → $330M (-$71.3M)
Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
37
Reduced
26
Closed
19
Calls
$3.15M
Puts
$3.54M
Net Calls
-$389K
Net Calls Change
+$1.07M
Top Buyers
| 1 |
BlackRock
New York
|
+$8.09M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.25M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$5.29M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.88M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.88M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$15.3M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$11.1M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.58M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.39M |
| 5 |
Millennium Management
New York
|
-$2.87M |
